Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI), a biopharmaceutical company specializing in CNS disorder therapeutics, has announced their CEO Sharon Mates will present at three major investor conferences in December 2024. The presentations are scheduled for: the Evercore 7th Annual HealthCONx Conference on December 3 at 10:50 a.m. ET in Miami, the Citi 2024 Global Healthcare Conference on December 4 at 3:15 p.m. ET in Miami, and the Piper Sandler 36th Annual Healthcare Conference on December 5 at 11:30 a.m. ET in New York. Live and archived webcasts will be available on the company's website.

News Market Reaction – ITCI

+1.07%

+1.07% Session move

In the trading session that priced this news, ITCI gained 1.07%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEDMINSTER, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences:

Evercore 7th Annual HealthCONx Conference
Tuesday, December 3, 2024 at 10:50 a.m. ET in Miami, FL

Citi 2024 Global Healthcare Conference
Wednesday, December 4, 2024 at 3:15 p.m. ET in Miami, FL

Piper Sandler 36th Annual Healthcare Conference
Thursday, December 5, 2024 at 11:30 a.m. ET in New York, NY

A live and achieved webcast of the presentations can be accessed under "Events & Presentations" in the Investors section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406

FAQ

When is Intra-Cellular Therapies (ITCI) presenting at the Evercore HealthCONx Conference 2024?

Intra-Cellular Therapies (ITCI) is presenting at the Evercore HealthCONx Conference on Tuesday, December 3, 2024, at 10:50 a.m. ET in Miami, FL.

Which investor conferences is ITCI attending in December 2024?

ITCI is attending three conferences: Evercore HealthCONx Conference (Dec 3), Citi Global Healthcare Conference (Dec 4), and Piper Sandler Healthcare Conference (Dec 5).

How can investors access ITCI's conference presentations in December 2024?

Investors can access live and archived webcasts of the presentations through the 'Events & Presentations' section of ITCI's website at www.intracellulartherapies.com.

Where will ITCI's presentations take place in December 2024?

ITCI's presentations will take place in Miami, FL (Evercore and Citi conferences) and New York, NY (Piper Sandler conference).